Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "protein with accessible thiol residue" refers generically to any protein containing a cysteine side chain whose thiol (–SH) group is exposed and chemically reactive on the protein surface. These residues are widespread in the proteome, serving key functions in redox regulation, catalysis, post-translational modification, protein folding and stability (via disulfide bonds), metal ion binding, and cellular signaling. Enzymes with accessible (or catalytic) cysteines include broad families such as thiol oxidoreductases, protein tyrosine phosphatases, and cysteine proteases. However, as a target definition, "protein with accessible thiol residue" is not a specific molecular entity or validated therapeutic target, but a chemical/structural property that can be found in thousands of different proteins with diverse biological roles and disease associations. Numerous research tools (e.g., thiol-reactive dyes, alkylators) and drugs interact with exposed protein thiols, but these typically lack selectivity, and widespread modification can disrupt protein function and cell viability, creating safety concerns. Monitoring protein thiol redox status is valuable as a biomarker of oxidative stress and disease. Note: This is not a standardized or canonical therapeutic target, but a descriptive category applied to many proteins. For any structured data set or drug discovery application, this entry is too generic and unspecific—any individual protein or enzyme must be referenced by its full standardized name (e.g., "Thioredoxin", "Glutathione S-transferase", "Protein tyrosine phosphatase 1B") for actionable targeting.
Covalent modification (alkylation, oxidation, or reduction of thiol group); Disulfide bond formation or cleavage; Inhibition of enzyme via modification of active site cysteine; Restoration of thiol redox status (e.g., by antioxidants); Chelation or detoxification via binding to metal-reactive thiols
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein with accessible thiol residue.